Wal-Mart is providing customers with a way to safely dispose of unused opioids; Kentucky's governor signs a bill to protect his Medicaid overhaul; Maryland coalition aims to ban price gouging for specialty and brand-name drugs.
Customers who fill opioid prescriptions at Wal-Mart will also receive a way to dispose of the drugs that prevent them from being misused. According to Reuters, customers will be given a packet of powder that they can mix with water and add to their pill bottle to dispose of unused opioids. The power and water mixture creates a biodegradable gel around the pills.
If a court were to strike down Kentucky’s overhaul of Medicaid, which requires able-bodied beneficiaries to work, then Governor Matt Bevin would strip half a million people of their coverage. The executive order Bevin signed would mostly affect adults added to the program after it was expanded under former Governor Steve Beshear, a Democrat, reported Courier Journal. So far, no legal challenge has been brought against Bevin’s overhaul of Medicaid, but several advocacy groups said it likely will be since some changes violate the federal law that establishes Medicaid.
The Maryland Health Care for All! Coalition is aiming to protect certain brand-name drugs from price gouging. AP reported that the coalition is trying to build on the success of a law in 2017 that was the first to prohibit price gouging of generic and off-patent drugs. Some of the drugs being targeted include those for multiple sclerosis, HIV/AIDS, and hepatitis C.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
FDA Expands Access to Approved CAR T-Cell Therapies by Eliminating REMS
June 30th 2025The FDA has removed Risk Evaluation and Mitigation Strategies (REMS) for approved chimeric antigen receptor (CAR) T-cell therapies for hematologic malignancies, aiming to ease provider burden and expand patient access.
Read More